Mannose-Binding Lectin: Clinical Implications for Infection, Transplantation, and Autoimmunity

Human Immunology

Volumn 67, Issue 4-5, 2006, Pages 247-256

  Bouwman, Lee H ^a   Roep, Bart O ^a   Roos, Anja ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; COMPLEMENT LECTIN PATHWAY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; GENETIC ANALYSIS; GRAFT REJECTION; HUMAN; INFECTION RISK; INFLAMMATORY DISEASE; INNATE IMMUNITY; MOLECULAR EPIDEMIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPLANTATION; VIRUS INFECTION;

AUTOIMMUNITY; HUMANS; INFECTION; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC; TRANSPLANTATION IMMUNOLOGY;

EID: 33646551483     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.030     Document Type: Review

References (98)

1. Turner M.W. Mannose-binding lectin. the pluripotent molecule of the innate immune system. Immunol Today 17 (1996) 532
2. Miller M.E., Seals J., Kaye R., and Levitsky L.C. A familial, plasma associated defect of phagocytosis. Lancet 60 (1968)
3. Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W., and Summerfield J.A. Molecular basis of opsonic defect in immunodeficient children. Lancet 337 (1991) 1569
4. Bouwman L.H., Roos A., Terpstra O.T., de Knijff P., van Hoek B., Verspaget H.W., Berger S.P., Daha M.R., Frolich M., van der Slik A.R., Doxiadis I.I., Roep B.O., and Schaapherder A.F. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 129 (2005) 408
5. Turner M.W., and Hamvas R.M. Mannose-binding lectin. structure, function, genetics and disease associations. Rev Immunogenet 2 (2000) 305
6. Nauta A.J., Raaschou-Jensen N., Roos A., Daha M.R., Madsen H.O., Borrias-Essers M.C., Ryder L.P., Koch C., and Garred P. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 33 (2003) 2853
7. Matsushita M., and Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 176 (1992) 1497
8. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B., and Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386 (1997) 506
9. Dahl M.R., Thiel S., Matsushita M., Fujita T., Willis A.C., Christensen T., Vorup-Jensen T., and Jensenius J.C. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15 (2001) 127
10. Matsushita M., Thiel S., Jensenius J.C., Terai I., and Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 165 (2000) 2637
11. Vorup-Jensen T., Petersen S.V., Hansen A.G., Poulsen K., Schwaeble W., Sim R.B., Reid K.B., Davis S.J., Thiel S., and Jensenius J.C. Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol 165 (2000) 2093
12. Zundel S., Cseh S., Lacroix M., Dahl M.R., Matsushita M., Andrieu J.P., Schwaeble W.J., Jensenius J.C., Fujita T., Arlaud G.J., and Thielens N.M. Characterization of recombinant mannan-binding lectin- associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. J Immunol 172 (2004) 4342
13. Sastry K., Herman G.A., Day L., Deignan E., Bruns G., Morton C.C., and Ezekowitz R.A. The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 170 (1989) 1175
14. Roos A., Garred P., Wildenberg M.E., Lynch N.J., Munoz J.R., Zuiverloon T.C., Bouwman L.H., Schlagwein N., Fallaux van den Houten F.C., Faber-Krol M.C., Madsen H.O., Schwaeble W.J., Matsushita M., Fujita T., and Daha M.R. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 34 (2004) 2589
15. Minchinton R.M., Dean M.M., Clark T.R., Heatley S., and Mullighan C.G. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 56 (2002) 630
16. Madsen H.O., Garred P., Thiel S., Kurtzhals J.A., Lamm L.U., Ryder L.P., and Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155 (1995) 3013
17. Madsen H.O., Satz M.L., Hogh B., Svejgaard A., and Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 161 (1998) 3169
18. Garred P., Larsen F., Madsen H.O., and Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 40 (2003) 73 2003 Sep; 40 (2-4):73-84
19. Petersen S.V., Thiel S., Jensen L., Steffensen R., and Jensenius J.C. An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 257 (2001) 107
20. Roos A., Bouwman L.H., Munoz J., Zulverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., Klar- Mohamad N., Hack C.E., Tilanus M.G., and Daha M.R. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 39 (2003) 655
21. Garred P., Larsen F., Seyfarth J., Fujita R., and Madsen H.O. Mannose-binding lectin and its genetic variants. Genes Immun (2006)
22. Garred P., Madsen H.O., Hofmann B., and Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 346 (1995) 941
23. Summerfield J.A., Ryder S., Sumiya M., Thursz M., Gorchein A., Monteil M.A., and Turner M.W. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 345 (1995) 886
24. Koch A., Melbye M., Sorensen P., Homoe P., Madsen H.O., Molbak K., Hansen C.H., Andersen L.H., Hahn G.W., and Garred P. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. J Am Med Assoc 285 (2001) 1316
25. Hibberd M.L., Sumiya M., Summerfield J.A., Booy R., Levin M., and Meningococcal Research Group. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet 353 (1999) 1049
26. Peterslund N.A., Koch C., Jensenius J.C., and Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358 (2001) 637
27. Mullighan C.G., Heatley S., Doherty K., Szabo F., Grigg A., Hughes T.P., Schwarer A.P., Szer J., Tait B.D., Bik T.L., and Bardy P.G. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 99 (2002) 3524
28. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard A., Holby N., Schwartz M., and Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104 (1999) 431
29. Roy S., Knox K., Segal S., Griffiths D., Moore C.E., Welsh K.I., Smarason A., Day N.P., McPheat W.L., Crook D.W., and Hill A.V. MBL genotype and risk of invasive pneumococcal disease. a case-control study. Lancet 359 (2002) 1569 2002 May 4;359 (9317):1569-73
30. Kronborg G., and Garred P. Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet 360 (2002) 1176
31. Eisen D.P., and Minchinton R.M. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37 (2003) 1496 2003 Dec 1;37 (11):1496-505
32. Siassi M., Hohenberger W., and Riese J. Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans 31 (2003) 774
33. Siassi M., Riese J., Steffensen R., Meisner M., Thiel S., Hohenberger W., and Schmidt J. Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care 9 (2005) R483
34. Garred P., Harboe M., Oettinger T., Koch C., and Svejgaard A. Dual role of mannan-binding protein in infections. another case of heterosis?. Eur J Immunogenet 21 (1994) 125
35. Thomas H.C., Foster G.R., Sumiya M., McIntosh D., Jack D.L., Turner M.W., and Summerfield J.A. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 348 (1996) 1417
36. Yuen M.F., Lau C.S., Lau Y.L., Wong W.M., Cheng C.C., and Lai C.L. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology 29 (1999) 1248
37. Hakozaki Y., Yoshba M., Sekiyama K., Seike E., Iwamoto J., Mitani K., Mine M., Morizane T., Ohtani K., Suzuki Y., and Wakamiya N. Mannose-binding lectin and the prognosis of fulminant hepatic failure caused by HBV infection. Liver 22 (2002) 29
38. Matsushita M., Hijikata M., Ohta Y., Iwata K., Matsumoto M., Nakao K., Kanai K., Yoshida N., Baba K., and Mishiro S. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 143 (1998) 645
39. Matsushita M., Hijikata M., Matsushita M., Ohta Y., and Mishiro S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol 29 (1998) 695
40. Sasaki K., Tsutsumi A., Wakamiya N., Ohtani K., Suzuki Y., Watanabe Y., Nakayama N., and Koike T. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol 35 (2000) 960
41. Kilpatrick D.C., Delahooke T.E., Koch C., Turner M.L., and Hayes P.C. Mannan-binding lectin and hepatitis C infection. Clin Exp Immunol 132 (2003) 92
42. Maas J., Roda Husman A.M., Brouwer M., Krol A., Coutinho R., Keet I., van Leeuwen R., and Schuitemaker H. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study. AIDS 12 (1998) 2275
43. Heggelund L., Mollnes T.E., Ueland T., Christophersen B., Aukrust P., and Froland S.S. Mannose-binding lectin in HIV infection. relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr 32 (2003) 354
44. Ezekowitz R.A., Kuhlman M., Groopman J.E., and Bym R.A. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169 (1989) 185
45. Salfuddin M., Hart M.L., Gewurz H., Zhang Y., and Spear G.T. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 81 (2000) 949
46. Hart M.L., Saifuddin M., Uemura K., Bremer E.G., Hooker B., Kawasaki T., and Spear G.T. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res Hum Retro viruses 18 (2002) 1311
47. Ying H., Ji X., Hart M.L., Gupta K., Saifuddin M., Zariffard M.R., and Spear G.T. Interaction of mannose- binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses 20 (2004) 327
48. Homoe P., Madsen H.O., Sandvej K., Koch A., and Garred P. Lack of association between mannose- binding lectin, acute otitis media and early Epstein-Barr virus infection among children in Greenland. Scand J Infect Dis 31 (1999) 363
49. Nielsen H.E., Siersma V., Andersen S., Gahm-Hansen B., Mordhorst C.H., Norgaard-Pedersen B., Roder B., Sorensen T.L., Temme R., and Vestergaard B.F. Respiratory syncytial virus infection-risk factors for hospital admission. a case-control study. Acta Paediatr 92 (2003) 1314
50. Kristensen I.A., Thiel S., Steffensen R., Madhi S., Sorour G., and Olsen J. Mannan-binding lectin and RSV lower respiratory tract infection leading to hospitalization in children. a case-control study from Soweto, South Africa. Scand J Immunol 60 (2004) 184
51. Kase T., Suzuki Y., Kawai T., Sakamoto T., Ohtani K., Eda S., Maeda A., Okuno Y., Kurimura T., and Wakamiya N. Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97 (1999) 385
52. Thielens N.M., Tacnet-Delorme P., and Arlaud G.J. Interaction of C1q and mannan-binding lectin with viruses. Immunobiology 205 (2002) 563
53. Leff J.A., and Repine J.E. Blood cells and ischemia-reperfusion injury. Blood Cells 16 (1990) 183
54. Sheron N., and Eddleston A. Preservation-reperfusion injury, primary graft non-function and tumour necrosis factor. J Hepatol 16 (1992) 262
55. Keith F. Oxygen free radicals in cardiac transplantation. J Card Surg 8 (1993) 245
56. Rudiger H.A., Graf R., and Clavien P.A. Liver ischemia. apoptosis as a central mechanism of injury. J Invest Surg 16 (2003) 149
57. Riedemann N.C., and Ward P.A. Complement in ischemia reperfusion injury. Am J Pathol 162 (2003) 363
58. Weisman H.F., Bartow T., Leppo M.K., Marsh Jr. H.C., Carson G.R., Concino M.F., Boyle M.P., Roux K.H., Weisfeldt M.L., and Fearon D.T. Soluble human complement receptor type 1. in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249 (1990) 146
59. Collard C.D., Vakeva A., Bukusoglu C., Zund G., Sperati C.J., Colgan S.P., and Stahl G.L. Reoxygenation of hypoxic human umbilical veln endothelial cells activates the classic complement pathway. Circulation 96 (1997) 326
60. Collard C.D., Agah A., and Stahl G.L. Complement activation following reoxygenation of hypoxic human endothellal cells. role of intracellular reactive oxygen species, NF-kappaB and new protein synthesis. Immunopharmacology 39 (1998) 39
61. Buerke M., Murohara T., and Lefer A.M. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 91 (1995) 393
62. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., and Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105 (2000) 1363
63. de Vries B., Matthijsen R.A., Wolfs T.G., Van Bijnen A.A., Heeringa P., and Buurman W.A. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury. Inhibition of late apoptosis and inflammation. Transplantation 75 (2003) 375
64. Collard C.D., Vakeva A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., Buras J.A., Meri S., and Stahl G.L. Complement activation after oxidative stress. role of the lectin complement pathway. Am J Pathol 156 (2000) 1549
65. Collard C.D., Montalto M.C., Reenstra W.R., Buras J.A., and Stahl G.L. Endothelial oxidative stress activates the lectin complement pathway. role of cytokeratin 1. Am J Pathol 159 (2001) 1045
66. Walsh M.C., Bourcier T., Takahashi K., Shi L., Busche M.N., Rother R.P., Solomon S.D., Ezekowitz R.A., and Stahl G.L. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 175 (2005) 541
67. Hart M.L., Ceonzo K.A., Shaffer L.A., Takahashi K., Rother R.P., Reenstra W.R., Buras J.A., and Stahl G.L. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 174 (2005) 6373
68. de Vries B., Walter S.J., Peutz-Kootstra C.J., Wolfs T.G., van Heum L.W., and Buurman W.A. The mannose- binding lectin-pathway is involved in complement activation in the course of renal ischemia- reperfusion injury. Am J Pathol 165 (2004) 1677
69. Berger S.P., Roos A., Mallat M.J., Fujita T., de Fijter J.W., and Daha M.R. Association between mannose- binding lectin levels and graft survival in kidney transplantation. Am J Transplant 5 (2005) 1361
70. Bouwman L.H., Roos A., Terpstra O.T., de Knijff P., van Hoek B., Verspaget H.W., Berger S.P., Daha M.R., Frolich M., van der Slik A.R., Doxiadis I.I., Roep B.O., and Schaapherder A.F. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 129 (2005) 408
71. Carroll M. Innate immunity in the etiopathology of autoimmunity. Nat Immunol 2 (2001) 1089
72. Ezekowitz R.A. Role of the mannose-binding lectin in innate immunity. J Infect Dis 187 Suppl 2 (2003) S335
73. Nauta A.J., Castellano G., Xu W., Woltman A.M., Borrias M.C., Daha M.R., van Kooten C., and Roos A. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol 173 (2004) 3044
74. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., and van Kooten C. Mini-review. A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34 (2004) 921
75. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., and Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194 (2001) 781
76. Stuart L.M., Takahashi K., Shi L., Savill J., and Ezekowitz R.A. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 174 (2005) 3220
77. Duvall E., Wyllie A.H., and Morris R.G. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 56 (1985) 351
78. Russell L., Waring P., and Beaver J.P. Increased cell surface exposure of fucose residues is a late event in apoptosis. Biochem Biophys Res Commun 250 (1998) 449
79. Garred P., Voss A., Madsen H.O., and Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun (2001) 442 2001 Dec; 2(8):442-502
80. Ohlenschlaeger T., Garred P., Madsen H.O., and Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351 (2004) 260
81. Seelen M.A., van der Bijl E.A., Trouw L.A., Zuiverloon T.C., Munoz J.R., Fallaux-van den Houten F.C., Schlagwein N., Daha M.R., Huizinga T.W., and Roos A. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus. Rheumatology (Oxford) 44 (2005) 111-119
82. Day J.F., Thomburg R.W., Thorpe S.R., and Baynes J.W. Carbohydrate-mediated clearance of antibody. antigen complexes from the circulation. The role of high mannose oligosaccharides in the hepatic uptake of IgM, antigen complexes. J Biol Chem 255 (1980) 2360
83. Sato R., Matsushita M., Miyata M., Sato Y., Kasukawa R., and Fujita T. Substances reactive with mannose-binding protein (MBP) in sera of patients with rheumatoid arthritis. Fukushima J Med Sci 43 (1997) 99
84. Graudal N.A., Homann C., Madsen H.O., Svejgaard A., Jurik A.G., raudal H.K., and Garred P. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 25 (1998) 629
85. Garred P., Madsen H.O., Marquart H., Hansen T.M., Sorensen S.F., Petersen J., Volck B., Svejgaard A., Graudal N.A., Rudd P.M., Dwek R.A., Sim R.B., and Andersen V. Two edged role of mannose binding lectin in rheumatoid arthritis. a cross sectional study. J Rheumatol 27 (2000) 26
86. Ip W.K., Lau Y.L., Chan S.Y., Mok C.C., Chan D., Tong K.K., and Lau C.S. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 43 (2000) 1679
87. Jacobsen S., Madsen H.O., Klarlund M., Jensen T., Skjodt H., Jensen K.E., Svejgaard A., Garred P., and TIRA Group. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. J Rheumatol 28 (2001) 935
88. Saevarsdottir S., Vikingsdottir T., Vikingsson A., Manfredsdottir V., Geirsson A.J., and Valdimarsson H. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study. J Rheumatol 28 (2001) 5728
89. Bouwman L.H., Eerligh P., Terpstra O.T., Daha M.R., de Knijff P., Ballieux B.E., Bruining G.J., van der Slik A.R., Roos A., and Roep B.O. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes 54 (2005) 3002
90. Hansen T.K., Tamow L., Thiel S., Steffensen R., Stehouwer C.D., Schalkwjk C.G., Parving H.H., and Flyvbjerg A. Association between mannose-binding lectin and vascular complications in type 1 diabetes. iabetes 53 (2004) 1570
91. Hovind P., Hansen T.K., Tarnow L., Thiel S., Steffensen R., Flyvbjerg A., and Parving H.H. Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes. an inception cohort study. Diabetes 54 (2005) 1523
92. Sarahelmo M., Forsblom C., Hansen T.K., Teppo A.M., Fagerudd J., Petterson-Femholm K., Thiel S., Tamow L., Ebeling P., Flyvbjerg A., and Groop P.H. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48 (2005) 198
93. Saevarsdott S., Oskarsson O.O., Aspelund T., Eiriksdottir G., Vikingsdottir T., Gudnason V., and Valdimarsson H. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 201 (2005) 117
94. Summerfield J.A. Clinical potential of mannose-binding lectin-replacement therapy. Biochem Soc Trans 31 (2003) 770
95. Valdimarsson H. Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochem Soc Trans 31 (2003) 768
96. Valdimarsson H., Vikingsdottir T., Bang P., Saevarsdottir S., Gudjonsson J.E., Oskarsson O., Christiansen M., Blou L., Laursen I., and Koch C. Human plasma-derived mannose-binding lectin. a phase I safety and pharmacokinetic study. Scand J Immunol 59 (2004) 97
97. Knezevic-Maramica I., and Kruskall M.S. Intravenous immune globulins. an update for clinicians. Transfusion 43 (2003) 1460
98. Wallington T. New uses for IVIgG immunoglobulin therapies. Vox Sang 87 Suppl 2 (2004) 155